• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨越三十年的囊性纤维化患者的教育、就业和收入 - 使用丹麦健康登记的匹配队列研究。

Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registries.

机构信息

Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark.

Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark.

出版信息

J Cyst Fibros. 2024 Sep;23(5):836-841. doi: 10.1016/j.jcf.2024.03.009. Epub 2024 Mar 14.

DOI:10.1016/j.jcf.2024.03.009
PMID:38485602
Abstract

BACKGROUND

Past and ongoing advancements in cystic fibrosis (CF) care warrant long-term analysis of the societal impact of the condition. This study aims to evaluate changes in key socioeconomic factors across three decades among people living with CF (pwCF), compared with both the general population and an early-onset chronic disease population.

METHODS

This nationwide, registry-based, matched cohort study included all pwCF ≥ 18 years in Denmark in the years 1990, 2000, 2010, and 2018. Each person living with CF was matched to five individuals in the general population and five individuals living with type 1 diabetes or juvenile arthritis based on age, sex, and municipality.

RESULTS

The Danish adult CF population increased nearly fourfold from 88 in 1990 to 331 in 2018, and mean age increased by ten years. The educational level of pwCF was similar to the two comparator cohorts, while pwCF were less often in employment and more often permanently outside the labor force. Personal and household income levels of the CF cohort were higher than those of the comparator cohorts.

CONCLUSIONS

The disadvantage in employment for pwCF remained, but, over time, the societal profiles of the one-year CF cohorts increasingly converged with those of the comparator cohorts, indicative of improved clinical management, extended life expectancy, and the supportive role of the Danish welfare system in reducing health inequalities. Further research should be done to evaluate the effects of the newly introduced modulator therapies on employment, considering the broader societal impact and impact on quality of life.

摘要

背景

囊性纤维化(CF)护理的过去和正在取得的进展需要对该疾病的社会影响进行长期分析。本研究旨在评估与普通人群和早发性慢性疾病人群相比,CF 患者(pwCF)中关键社会经济因素在过去三十年中的变化。

方法

这是一项全国范围内基于登记的匹配队列研究,纳入了丹麦 1990 年、2000 年、2010 年和 2018 年≥18 岁的所有 pwCF。每一位 CF 患者都与普通人群中的五个人和患有 1 型糖尿病或幼年特发性关节炎的人群中的五个人相匹配,匹配的因素包括年龄、性别和市。

结果

丹麦成人 CF 患者人数从 1990 年的 88 人增加到 2018 年的 331 人,几乎增加了四倍,平均年龄增加了十岁。pwCF 的教育水平与两个对照组相似,而 pwCF 的就业率较低,长期处于非劳动力状态的比例较高。CF 队列的个人和家庭收入水平高于对照组。

结论

pwCF 的就业劣势仍然存在,但随着时间的推移,每年 CF 队列的社会特征与对照组越来越趋同,表明临床管理得到了改善,预期寿命延长,丹麦福利制度在减少健康不平等方面发挥了支持作用。应进一步研究新引入的调节剂治疗对就业的影响,考虑到更广泛的社会影响和对生活质量的影响。

相似文献

1
Education, employment, and income among people living with cystic fibrosis across three decades - A matched cohort study using Danish health registries.跨越三十年的囊性纤维化患者的教育、就业和收入 - 使用丹麦健康登记的匹配队列研究。
J Cyst Fibros. 2024 Sep;23(5):836-841. doi: 10.1016/j.jcf.2024.03.009. Epub 2024 Mar 14.
2
Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor/ivacaftor: an assessment using linked registry data in Sweden.囊性纤维化的临床、经济和社会负担,以及 CFTR 调节剂 lumacaftor/ivacaftor 的影响:瑞典基于注册登记数据的评估。
J Med Econ. 2024 Jan-Dec;27(1):897-906. doi: 10.1080/13696998.2024.2373000. Epub 2024 Jul 6.
3
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对具有 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(含或不含增效剂)。
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD010966. doi: 10.1002/14651858.CD010966.pub3.
4
Bipolar disorder and depression in early adulthood and long-term employment, income, and educational attainment: A nationwide cohort study of 2,390,127 individuals.双相情感障碍和成年早期抑郁与长期就业、收入和教育程度的关系:一项针对 2390127 人的全国性队列研究。
Depress Anxiety. 2019 Nov;36(11):1080-1088. doi: 10.1002/da.22956. Epub 2019 Sep 11.
5
[Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].[意大利囊性纤维化登记处(ICFR)。2021 - 2022年报告]
Epidemiol Prev. 2024 Mar-Apr;48(2 Suppl 2):1-41. doi: 10.19191/EP24.2.S2.031.
6
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
7
Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.使用基线特征对囊性纤维化患者进行最新和预计的生存估计:一项使用英国患者登记数据的纵向研究。
J Cyst Fibros. 2018 Mar;17(2):218-227. doi: 10.1016/j.jcf.2017.11.019. Epub 2018 Jan 6.
8
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.2020 年 2 月至 6 月期间欧洲囊性纤维化患者中 SARS-CoV-2 的发病率。
J Cyst Fibros. 2021 Jul;20(4):566-577. doi: 10.1016/j.jcf.2021.03.017. Epub 2021 Apr 18.
9
The association between early-onset schizophrenia with employment, income, education, and cohabitation status: nationwide study with 35 years of follow-up.早发性精神分裂症与就业、收入、教育和同居状况的关联:一项全国性研究,随访 35 年。
Soc Psychiatry Psychiatr Epidemiol. 2019 Nov;54(11):1343-1351. doi: 10.1007/s00127-019-01756-0. Epub 2019 Aug 27.
10
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study.在一项正在进行的基于登记的研究中,2 至 5 岁囊性纤维化儿童使用 lumacaftor/ivacaftor 起始治疗对疾病进展的疗效:中期结果。
J Cyst Fibros. 2024 May;23(3):436-442. doi: 10.1016/j.jcf.2024.02.004. Epub 2024 Feb 23.